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Edited by Karen FlemingTalin (TLN1) is a mechanosensitive component of adhesion
complexes that directly couples integrins to the actin cyto-
skeleton. In response to force, talin undergoes switch-like
behavior of its multiple rod domains that modulate in-
teractions with its binding partners. Cyclin-dependent kinase-1
(CDK1) is a key regulator of the cell cycle, exerting its effects
through synchronized phosphorylation of a large number of
protein targets. CDK1 activity maintains adhesion during
interphase, and its inhibition is a prerequisite for the tightly
choreographed changes in cell shape and adhesion that are
required for successful mitosis. Using a combination of
biochemical, structural, and cell biological approaches, we
demonstrate a direct interaction between talin and CDK1 that
occurs at sites of integrin-mediated adhesion. Mutagenesis
demonstrated that CDK1 contains a functional talin-binding
LD motif, and the binding site within talin was pinpointed to
helical bundle R8. Talin also contains a consensus CDK1
phosphorylation motif centered on S1589, a site shown to be
phosphorylated by CDK1 in vitro. A phosphomimetic mutant
of this site within talin lowered the binding affinity of the
cytoskeletal adaptor KANK and weakened the response of this
region to force as measured by single molecule stretching,
potentially altering downstream mechanotransduction path-
ways. The direct binding of the master cell cycle regulator
CDK1 to the primary integrin effector talin represents a
coupling of cell proliferation and cell adhesion machineries
and thereby indicates a mechanism by which the microenvi-
ronment can control cell division in multicellular organisms.
Cell adhesion to the extracellular matrix (ECM) is required
for anchorage-dependent cell survival and growth in multi-
cellular organisms. During the G1 commitment phase of the‡ These authors contributed equally to this work.
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thesis (1, 2) and suppress apoptosis (3, 4). However, how
changes in adhesion signaling are able to influence cell cycle
progression in adherent cells is only partly elucidated. During
mitosis, major changes in integrin adhesion complexes (IACs),
cytoskeletal architecture, and cell shape are obligatory for
chromosome segregation and cytokinesis (5–8). These
remodeling events can be so extensive that cells become round
and virtually lose their adhesion. Despite the risks to tissue
integrity, the optimally symmetrical geometry of a sphere ap-
pears to enable the high degree of precision required for
chromosome capture and division plane orientation (9–11).
Suppression of these changes during mitosis perturbs the
ability of cells to divide accurately (12–14). All of these
changes are highly conserved, implying the existence of a
primordial regulatory mechanism linking the cell cycle and
adhesion machineries.
One link between the cell cycle and adhesion is mediated
through the master regulator of the cell cycle, cyclin-
dependent kinase-1 (CDK1). CDK1 is a serine/threonine ki-
nase that partners with cyclins that control both kinase activity
and substrate specificity (15). CDK1 inhibition leads to
disassembly of IACs, suggesting that CDK1 activity has an
interphase role in promoting integrin-mediated adhesion and
actomyosin organization (12, 16). IAC area increases during
S phase in a CDK1-dependent manner, then inhibition of
CDK1 through Wee1-mediated phosphorylation in G2 causes
IAC loss in preparation for entry into mitosis (12). Together,
these findings identify a key role for CDK1 in the regulation of
adhesion during cell cycle progression.
Talins are large (270 kDa) multidomain proteins composed
of an N-terminal head coupled to a large rod comprising 13
helical bundles (R1-R13) (17). The two talin isoforms (talin-1/
TLN1 and talin-2/TLN2) are considered to be the principal
proteins that couple integrins to F-actin. The N-terminal
FERM domain binds to integrin cytoplasmic domains (18–21),
and two sites in the C-terminal flexible rod domain bindJ. Biol. Chem. (2021) 297(1) 100837 1
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A direct interaction between talin and CDK1F-actin (22, 23). Talin binding to integrins is maintained by
actomyosin-generated force and results in conformational
activation of integrins (20). The linkage therefore provides a
regulatable means of controlling cell adhesion to the ECM
from within the cell. This trimolecular core also initiates the
recruitment of a large number of additional proteins, termed
the adhesome, which varies in composition between IAC type
(24–26), reflecting distinct effector, signaling, and mechano-
sensing functions. The role of talin as a key mechano-
transducer relies on its ability to undergo force-dependent
structural rearrangements. As force from actin is exerted on
talin anchored to integrins, the talin rod gradually unfolds at
discrete sites, resulting in both the displacement and recruit-
ment of signaling proteins. This enables talin to serve as a
mechanosensitive signaling hub, integrating a wide range of
signals to produce diverse cellular responses (27).
Here, we identify a direct interaction between CDK1 and
talin through an unbiased analysis of talin-binding proteins.
CDK1 contains a talin-binding LD motif that interacts directly
with the R8 domain of talin. This interaction is required for
regulating CDK1 function at IACs and leads to an alteration in
the mechanosensitivity of talin. Direct mechanical coupling of
the master cell cycle regulator and the principal integrin
effector provides an elegant mechanism coupling the cell di-
vision and adhesion machineries to facilitate proliferation in a
multicellular environment.
Results
Talin associates with CDK1 at adhesion sites
To identify novel talin-binding proteins, full-length talin-1
fused to GFP was expressed in U2OS cells and interacting
proteins identified by GFP-Trap pull-down and mass spec-
trometry. Multiple proteins were identified, including previ-
ously characterized ligands such as vinculin, integrins, and two
of the four KANK (KN Motif and Ankyrin Repeat Domains)
proteins, KANK2 and KANK3 (Fig. 1A and Table S1). In
addition, peptides covering a large proportion of CDK1
(SAINT Score 0.96) were detected with high confidence in all
three talin pull-downs, but never in the GFP controls, sug-
gesting that CDK1 also associates with talin. The mass spec-
trometry data were confirmed by western blotting of the GFP-
talin pull-down with anti-CDK1 antibody (Fig. 1B). To support
these findings, CDK1 was tagged with BirA*, expressed in
U2OS cells, and BioID proximity biotinylation employed to
label proteins close to CDK1 in situ. Using this approach, 118
labeled proteins were identified, including the known CDK1
interactors, cyclin B1 and cyclin B2 (Table S2). 47% of the
identified proteins were found within the meta adhesome,
suggestive of a role for CDK1 in regulating adhesion/cyto-
skeletal dynamics (28). Furthermore, in addition to talin, the
core adhesome components, vinculin, paxillin, filamin A, and
CRK, were in close proximity to CDK1 (Fig. 1C). Finally, TIRF
microscopy was employed to determine the localization of
CDK1 at the cell–ECM interface. mScarlet-CDK1 was
distributed in elongated, fleck-like structures that partially
overlapped with GFP-talin-containing IACs (Fig. 1D). Taken2 J. Biol. Chem. (2021) 297(1) 100837together, these findings indicate a close association between
talin and CDK1 at sites of integrin-mediated adhesion to the
ECM.
CDK1 contains an LD motif that binds directly to talin R8
We next aimed to identify the binding interface between
talin and CDK1. Talin contains multiple binding sites for
proteins that contain leucine/aspartic acid LD motifs, with a
consensus sequence I/LDxØØxØØ (where Ø denotes a hy-
drophobic residue) (29, 30). These amphipathic helical peptide
motifs engage talin via a helix-addition mechanism (31, 32),
packing on the side of the helical bundles in the talin rod. This
mode of binding allows mechanosensitive regulation as it only
occurs when the talin rod domain mediating the interaction is
folded: unfolding due to mechanical force disrupts the LD
motif binding site and the connection is severed (27).
Analysis of the CDK1 protein sequence identified a highly
conserved, consensus LD motif sequence between residues
206 and 223 (Fig. 2, A and B), which we postulated might
bind directly to talin. Fluorescence polarization was employed
to test direct binding, as described previously (33, 34). In this
assay, a synthetic peptide spanning the CDK1 LD motif,
CDK1(206–223), is fluorescently tagged and titrated against
an increasing concentration of unlabeled talin fragment; any
binding between the two polypeptides results in an increase
in the fluorescence polarization signal. To identify the puta-
tive CDK1-binding site(s) on talin, six talin fragments were
generated that span the whole molecule; F0-F3, R1-R3, R4-
R8, R9-R10, R11-R12 and R13-DD (Fig. 2C). Two of these
fragments incorporate the actin-binding sites in the talin rod,
ABS2 (R4-R8 (23, 35)) and ABS3 (R13-DD (36, 37)). No
significant interaction was observed between CDK1(206–223)
and the talin Head, R9-R10, R11-R12, or R13-DD fragments;
however, R4-R8 demonstrated increasing fluorescence po-
larization with increasing talin concentration, indicative of a
direct interaction (Fig. 2D). We note that a small change in
polarization was also detected with the R1-R3 fragment;
however, this interaction was too weak to be quantified and
is possibly the result of a nonspecific LD interaction with the
LD motif binding sites in R2 and R3 that bind the LD motifs
in RIAM (17). To further define the CDK1-binding site
within talin R4-R8, we tested binding to additional rod
domain constructs. Talin R4-R6 demonstrated negligible
binding to CDK1(206–223), whereas R7R8 bound to
CDK1(206–223) with a Kd of 15 μM (Fig. 2E). The R7R8
region of both talin isoforms, talin-1 and talin-2, bound
CDK1(206–223) with similar affinity (Fig. 2E). As found for
other LD motif peptides (34), mutation of the LD motif
within CDK1 to two alanine residues (to generate a 2A
mutant; Fig. 3, A and B) markedly reduced the interaction
with talin (Fig. 3C).
The CDK1 LD motif binding pocket on talin R8 differs from
that of DLC1 and RIAM
We initially used NMR to characterize the interaction be-
tween CDK1 and talin. HSQC spectra of 15N-labeled talin-1
Figure 1. Talin interacts with CDK1. A, Mass Spectrometry (MS) analysis of GFP-tagged talin-1 binding proteins, displayed as a volcano plot. The fold-
change enrichment over GFP alone is plotted against the significance of the association. The SAINT score and the FC_B scores were calculated using
the REPRINT (Resource for Evaluation of Protein Interaction Network) online tool (https://reprint-apms.org/). The volcano plot was generated using Vol-
caNoseR (70). Key putative talin-1 binders, including CDK1, are highlighted. B, GFP-Trap pull-down of GFP alone or GFP-talin-1 expressed in U2OS cells
followed by western blotting for GFP, actin, and CDK1. C, MS analysis of proteins biotinylated by BirA*-CDK1, indicating proteins in close proximity to CDK1
in cells. Proteins shown in the table are core components of IACs. D, TIRF image of a U2OS cell coexpressing GFP-talin-1 and mScarlet-CDK1. Scale bar
10 μm.
A direct interaction between talin and CDK1R7R8 were collected in the absence and presence of increasing
amounts of CDK1(206–223) peptide (Fig. 3D). Addition of
CDK1(206–223) peptide, but not CDK1-2A, resulted in pro-
gressive chemical shift changes to a subset of the R8 residues,
indicative of a direct, specific interaction. Using the chemical
shift assignments of the R8 domain of talin-1 (BMRB ID:19339
(32)), the changes were mapped onto the structure of R8 (PDB
ID: 2X0C (38)). The changes mapped onto one face of the R8domain, the same region that binds the LD motifs of DLC1
(32) and RIAM (17, 39) (Fig. 3E). To support the requirement
for the talin R8 domain in interacting with CDK1, GFP-Trap
pull-downs were performed using wild-type (WT) full-length
talin or talin lacking the R8 domain (ΔR8). WT-talin-1-GFP
pulled down HA-tagged CDK1-WT, but not HA-CDK1-2A,
whereas ΔR8-talin-1-GFP failed to associate with HA-CDK1-
WT (Fig. 3F).J. Biol. Chem. (2021) 297(1) 100837 3
Figure 2. CDK1 interacts with the talin R8 domain. A, sequence alignment of the previously reported talin-binding LD motifs, paxillin LD1, RIAM, DLC1,
KANK1, and KANK2, with CDK1. Acidic (red), basic (blue), and hydrophobic (green) residues are highlighted. B, sequence alignment of the CDK1 region
containing the talin binding site. The talin-binding LD motif is highlighted in bold. Aligned sequences were human (UniProt P06493), mouse (UniProt
P11440), Drosophila melanogaster (UniProt P23572), Dictyostelium discoideum (UniProt P34112), Caenorhabditis elegans (UniProt P34556), and Saccharomyces
cerevisiae (UniProt P00546). C, schematic of the domain structure of talin. The five talin rod fragments screened for binding to CDK1 are highlighted: R1-R3
(residues 482–911, pink), R4-R8 (residues 913–1653, green), R9-R10 (residues 1655–2015, orange), R11-R12 (1974–2293, yellow), and R13-DD (2300–2542,
cyan). The 11 vinculin-binding sites are shown in black. The LD-binding domains identified to date are shown by a red asterisk. D and E, binding of BODIPY-
labeled CDK1(206–223) peptide to talin fragments measured using fluorescence polarization. Binding of BODIPY-labeled CDK1(206–223) peptide with (D)
the five talin-1 fragments and (E) with talin-1 and talin-2 R7R8 domains. Dissociation constants ±SE (μM) for the interactions are indicated in the legend. All
measurements were performed in triplicate. ND, not determined.
A direct interaction between talin and CDK1To resolve the structural basis of the talin-CDK1 interac-
tion, the R7R8-CDK1 peptide complex was crystallized and the
structure determined to 2.28 Å resolution (Fig. 4, A and B).
The structure contained two R7R8 molecules within the
asymmetric unit, each with CDK1 peptides localized to the
respective R8 domains (Fig. S1A; Table S3). Each peptide was
exceptionally resolved in both the F0-FC weighted difference
map and simulated annealing OMIT maps (Fig. S1, B and C).
Unexpectedly, the CDK1 peptide was oriented perpendicular
to the helices of the R8 fold, forming a pseudo-5-helix bundle
(Fig. 4, A and B) that contrasts with the helix-addition
mechanism of DLC1 and RIAM (32, 39) (Fig. 4, C and D).
This arrangement was supported by NMR chemical shift
mapping (Fig. 3E), where the shift changes upon addition of
CDK1 peptide were located predominantly at one end of the
LD motif binding surface of the bundle.4 J. Biol. Chem. (2021) 297(1) 100837The CDK1 peptide was identified on the basis of sequence
homology with the LD motif. In previous studies of LD motif
recognition, the aspartate residue of the LD motif was shown
to form a salt bridge with a positively charged residue on the
cognate-binding site (40), and in the case of DLC1, mutation of
talin K1544 abolished interactions with R8 (32). The CDK1-
talin structure deviated from this shared interaction mecha-
nism as K1544 was not involved in the interaction, but instead
oriented away from the CDK1-binding site. The isoleucine side
chain of the LD motif was responsible for displacing the K1544
side chain and an ID/AA double mutation attenuated the
CDK1-talin interaction (Fig. 4B). The remainder of the CDK1
peptide formed a hydrophobic interface with the R8 domain
with the CDK1 214FRIFRA219 sequence buried into a hydro-
phobic groove between the helices formed of talin residues
L1492, A1495, V1498, L1539, V1540, and I1543 (Fig. 4B).
Figure 3. The CDK1 LD motif is required for CDK1 binding to talin-1. A, CDK1 structure (PDB ID: 4YC3 (41)) with the talin-binding LD motif highlighted in
magenta. The LD motif consensus residues (E209, I210, D211, F214, and F217) and the I210A and D211A, 2A mutation are highlighted. B, aligned sequences
of CDK1 WT and CDK1-2A mutant peptides. C, binding of BODIPY-labeled CDK1 WT and 2A 206 to 223 peptide with talin-1 R7R8 domains using fluo-
rescence polarization. Dissociation constants ±SE (μM) for the interactions are indicated. All measurements were performed in triplicate. D, 1H,15N HSQC
spectra of 70 μM 15N-labeled talin-1 R8 (residues 1461–1580) (black) with 420 μM CDK1 peptide (green), 420 μM CDK1-2A peptide (red) added. E, mapping of
the CDK1-binding site on R8 as detected by NMR using weighted chemical shift differences (red)—mapped onto the R7R8 structure. F, GFP-Trap pull-downs
from cells expressing GFP alone, GFP-WT-talin-1, or GFP-ΔR8-talin-1 along with HA-tagged WT or 2A-CDK1, followed by western blotting for GFP and HA.
A direct interaction between talin and CDK1The CDK1 sequence formed an amphipathic helix that
closely resembled its conformation in full-length CDK1 (PDB
ID: 4YC6 (41)), where the key residues involved in talin
binding are surface exposed (Fig. S2). The structure of this
lobe of the kinase has been solved in complex with other
proteins such as CKS1 (cyclin-dependent regulatory subunit 1)
(41), suggesting it may play a role as a targeting domain. As the
CDK1 LD motif peptide superimposed on the CDK1 structure,
it was possible to model the interaction between talin and the
CDK1-cyclin B1 complex (Fig. 4, E and F). This demonstrated
that the talin–CDK1 interaction is unlikely to perturb CDK1
binding to regulatory cyclin proteins and suggests the possi-
bility that talin is able to interact with active CDK1-cyclin
complexes.Talin binding is required for CDK1-dependent regulation of
adhesion
We previously demonstrated that CDK1 kinase activity is
required to maintain IACs and to facilitate changes in IAC
area during cell cycle progression (12). To test whether
these functions were dependent on the interaction between
CDK1 and talin, the effects of mutant versions of both
proteins were determined. Consistent with previous data,
knockdown of CDK1 in asynchronous cells resulted in a
reduction in paxillin-positive IAC area that was rescued by
re-expression of siRNA-resistant WT CDK1, but not CDK1-
2A (which is unable to bind talin; Fig. S3, A and B). In
addition, in synchronized cells expressing CDK1-WT, the
robust IAC growth previously observed during S phase didJ. Biol. Chem. (2021) 297(1) 100837 5
Figure 4. Crystal structure of the talin-CDK1 complex. A and B, cartoon representation of the X-ray structure of the talin R7R8 fragment complex with
CDK1(206–223). Talin R8 (white) and CDK1 (magenta) are indicated. A, face on and B, side on views. Key residues are highlighted. C and D, structure of talin
R8-LD motif complexes. C, talin-DLC1 (PDB ID: 5FZT (32)) and D, talin-RIAM (PDB ID: 4W8P (39)), orientated as in (A). E and F, structural model of a talin-CDK1-
cyclin complex. E, modeled structure of talin (gray) bound to the complex of CDK1 (blue) and cyclin B1 (orange) using (PDB ID: 4YC3 (41)). F, structure of the
tripartite complex of CDK1 (blue), cyclin B1 (orange), and CKS2 (gray) (PDB ID: 4YC3). Talin R8 and CKS2 both bind CDK1 via the same region on the opposite
face to the cyclin-binding surface.
A direct interaction between talin and CDK1not occur in cells expressing CDK1-2A (Fig. S3C). These
findings indicate that the CDK1 LD motif is required for
CDK1 to maintain IACs in asynchronous cells and to
facilitate IAC growth during S phase. Subsequent analysis of
the CDK1-2A mutant protein demonstrated complexing
with cyclin B1, but not cyclin A2, and a lack of6 J. Biol. Chem. (2021) 297(1) 100837phosphorylation at the activating site T161 (Fig. S3, D and
E). While talin binding may therefore contribute to CDK1
activation, since CDK1-cyclin A2 maintains IACs (9), it
therefore cannot be concluded that the effects of CDK1-2A
on adhesion are solely attributable to the loss of CDK1
binding to talin.
A direct interaction between talin and CDK1In complementary studies, the effects of ΔR8-talin-1
expression on IACs were examined. In cells expressing WT
talin-1, a dose-dependent reduction in IAC area was observed
following treatment of cells with the CDK1 inhibitor RO3306.
In contrast, no loss of IAC area was observed in cells
expressing ΔR8-talin-1 (Fig. 5, A and B). Furthermore, in
synchronized cells expressing ΔR8-talin-1, IAC area remained
constant through G1, S, and G2, while cells expressing WT
talin-1 displayed IAC growth during S (Fig. 5C). These dataFigure 5. Talin-CDK1 interaction is required to facilitate CDK1-dependen
expressing GFP-WT-talin-1 or GFP-ΔR8-talin-1 treated with DMSO or two differ
cells treated with DMSO or RO3306. C, IAC area changes in G1, S, and G2 p
minimum of 50 cells per condition was used for analysis and results are displ
range). ****p < 0.0001.demonstrate that the talin R8 domain is required for facili-
tating CDK1-dependent regulation of IACs.
CDK1 phosphorylates talin R7R8 and modulates its
mechanosensitivity
Talin R8 binds to CDK1 in a similar region to the regulatory
CKS proteins that target CDK1 to specific substrates and
facilitate CDK1-dependent phosphorylation (41, 42). We
therefore hypothesized that binding of CDK1 to talin mightt regulation of adhesion complexes. A, confocal imaging of U2OS cells
ent doses of the CDK1 inhibitor RO3306. Bars 10 μm. B, IAC area changes in
hase for cells expressing GFP-WT-talin-1 or GFP-ΔR8-talin-1. For B and C, a
ayed as Tukey box and whisker plots (whiskers represent 1.5× interquartile
J. Biol. Chem. (2021) 297(1) 100837 7
A direct interaction between talin and CDK1lead to phosphorylation of residues within the R7R8 region.
Incubation of talin-1 R7R8 and CDK1-cyclin A with ATP
in vitro resulted in a high level of phosphorylation of R7R8
(Fig. 6, A and B), and subsequent analysis by mass spectrom-
etry identified a single phosphorylation at S1589. Furthermore,
sequence analysis identified the presence of a consensus CDK1
phosphorylation motif (SP) at S1589 (Fig. 6, B–D).
The positioning of the talin-1 phosphorylation site is at the
end of the R7 rod domain close to where R8 is inserted (Fig. 6, C
and D), and is adjacent to two charged residues D1451 and
E1591. We predicted that phosphorylation of S1589 might lead
to repulsion from these acidic residues, resulting in decreased
stability of both R7 and R8 and a potential weakening of the
binding of ligands to R7R8. To determine if S1589 phosphory-
lation affected the binding of KANK to R7 and DLC1 and CDK1
binding to R8 (32, 34), a talin phosphomimetic mutant
(S1589D) was designed and the binding affinity of the CDK1,
KANK, and DLC1 peptide ligands to R7R8 measured by fluo-
rescence polarization. Binding of both R8 ligands was largely
unaffected by the talin-1 S1589D mutation, but the affinity of
KANK binding was approximately fourfold lower (Kd 4 μMand
1 μM for the mutant and WT, respectively; Fig. 6, E and F).
These data indicate that S1589 phosphorylation does not
appreciably alter the binding surface of R8, but does have a
potentially significant change in binding of KANK to R7.
The stability and positioning of the R7 and R8 domains are
maintained by an extensive network of hydrogen bonds
between the linkers connecting the two domains forming a
two-stranded, antiparallel ß-sheet-like structure (38). As S1589
is located close to the linker between R7 and R8, it was
conceivable that the mechanosensitivity of this region may be
altered by CDK1-dependent phosphorylation. To test whether
posttranslational modification (PTM) of S1589 alters the
mechanical stability of the domains, we used single-molecule
unfolding experiments using magnetic tweezers (Fig. 7A).
Our previous study of the mechanical response of talin showed
that, when exposed to mechanical force, the R7R8 double
domain unfolds cooperatively with a single unfolding step of
80 nm at 15 pN force at a force loading rate of 3.4 pN s−1
(43). To further characterize the mechanical properties of
R7R8, single-molecule unfolding experiments were conducted
for an R7R8 construct at loading rates of 1.0 ± 0.1 and 5.0 ±
0.5 pN s−1. Consistent with our previous report (43), a coop-
erative unfolding event was observed indicated by a single
height-jump step of 70 nm at a force of 14 pN (Fig. 7B).
The normalized unfolding force distributions of R7R8 at force
loading rates of 1 ± 0.1 pN s−1 and 5 ± 0.5 pN s−1 peaked at
13.3 ± 1.6 pN and 14.5 ± 1.9 pN, respectively. Next, similar
force-increase scans were performed with a single-molecule
construct containing R7 alone (Fig. 7C). In this case, the
unfolding forces of the R7 domain were 10.1 ± 1.9 pN and
11.2 ± 1.1 pN for 1 ± 0.1 pN s−1 and 5 ± 0.5 pN s−1, respectively
(Fig. 7C), demonstrating that the R7 domain is mechanically
weaker than R7R8. As it has already been demonstrated that
R8 is mechanically weak (43, 44), these findings indicate that
the interdomain interaction between R7 and R8 is mutually
stabilizing.8 J. Biol. Chem. (2021) 297(1) 100837Next, to investigate how phosphorylation might affect the
mechanical stability of R7R8, a phosphomimetic single-
molecule construct of R7R8 containing S1589D (referred as
R7R8S1589D) was generated. The unfolding force of R7R8S1589D
peaked at 9.7 ± 1.5 pN and 10.0 ± 1.5 pN for 1 ± 0.1 pN s−1 and
5 ± 0.5 pN s−1, respectively, and was significantly reduced
compared with WT R7R8 (Fig. 7D). Furthermore, R7R8S1589D
and R7 had similar mechanical stabilities. These results
demonstrate that phosphorylation of S1589 weakens the
mechanical stability of this region likely by disrupting the
interdomain connection of R7 and R8.
Discussion
Much of our current understanding of cell cycle regulation
stems from studies on unicellular organisms, and less is known
about the mechanisms coordinating cell division in the ECM-
containing tissues of multicellular organisms. Here, our
principal discovery is that there is a direct binding interaction
between the master cell cycle regulator, CDK1, and talin, a
large mechanosensitive, actin-binding protein that plays a key
role in regulating integrin-mediated cell adhesion to ECMs.
We have employed biochemical and structural approaches to
define the binding mechanism and demonstrate that a helical,
talin-binding LD motif in CDK1 engages the talin rod R8
helical bundle. A CDK1-2A mutation, which disrupts the LD
motif, impedes the assembly of IACs. Talin also contains a
functional consensus CDK1 phosphorylation motif centered
on S1589, which regulates the mechanical responsiveness of
the region, and thereby potentially alters downstream
mechanotransduction pathways. Phosphorylation of talin
S1589 has been detected in multiple large-scale phosphopro-
teomic screens (45–47). We hypothesize that CDK1 binding to
the talin scaffold could be a driver of the major morphological
changes in adhesion seen during cell cycle progression and
division and that this constitutes an evolutionary adaptation of
the cell cycle that is fundamental to multicellularity.
Although we demonstrate that the talin-CDK1 interaction is
required for CDK1-dependent regulation of IACs during the
cell cycle, a more detailed understanding of the mechanisms
underlying this effect remains to be elucidated. For example,
the talin-CDK1 interaction might regulate phosphorylation of
multiple adhesome components, thereby contributing to IAC
dynamics and downstream signaling pathways. The talin R8
domain is a nexus for multiple binding interactions; thus, in
addition to CDK1, it binds DLC1 (32, 48), RIAM (17, 49), and
paxillin (32), which modulate various aspects of cell spreading
and migration, raising the possibility that competing in-
teractions might provide a novel regulatory axis. This is sup-
ported by the observation that deletion of R8 from talin results
in an increase in adhesion area, suggesting that additional
binding interactions with R8 are important in regulating IAC
dynamics. The unique structure of the R7R8 region, in which
the R8 helical bundle is inserted into the R7 helical bundle,
means that R8 is shielded from force, unfolding only when R7
unfolds at 14 pN applied force (43, 44). R8 therefore retains
its ability to form helical addition interactions with LD-motif-
containing proteins even when flanking talin domains have
Figure 6. CDK1-cyclin A2 phosphorylates talin-1. A, western blotting of talin-1 R7R8 phosphorylation by purified CDK1-cyclin A2 in the presence of ATP.
B, sequence of the phosphorylated Talin-1 peptide identified by the MS, the SP motif that contains the phosphorylation site at S1589 is highlighted. C, talin-
1 R7R8 structure with the phosphorylation site, S1589, highlighted in green. The binding sites for KANK on R7 and CDK1 on R8 are highlighted. D, region of
the structure highlighted by the dotted region in (C). The linker between the R7 and R8 domains forms a two-stranded antiparallel ß-sheet-like structure
mediated by a hydrogen bonding network (dashed yellow lines). The location of the S1589 residue (green spheres) relative to the acidic side chains of D1451
and E1591. E and F, binding of BODIPY-TMR labeled CDK1 206–223C, DLC1 465–489C, and KANK1 30–60C peptides to talin-1 R7R8 (1357–1653), (E) WT and
(F) S1589D. Binding affinities were measured by fluorescence polarization. Dissociation constants ±SE (μM) for the interactions are indicated.
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Figure 7. R7R8 module is mechanically stabilized by R7-R8 interdomain interaction. A, schematic of single-molecule stretching experiments where a
single protein tether, coupled between a paramagnetic bead and a surface, is stretched under force. B, Left panel, typical force–bead height curves of the
R7R8 construct during force-increase scans at a loading rate of 1 pN s−1. Each colored line indicates one independent force-increase scan, smoothed
(10-point fast Fourier transform) from raw data (gray). Right panel, the normalized unfolding force distributions of R7R8 complex during force-increase scans
at 1 pN s−1 and 5 pN s−1. The data points obtained for analysis are N = 62 and N = 195, respectively. The curves are Gaussian fitting of the distribution with
peaks at 13.3 ± 1.6 pN and 14.5 ± 1.9 pN, respectively. C, Left panel, typical force–bead height curves of R7 during force-increase scans at a loading rate of
1 pN s−1. Right panel, the normalized unfolding force distributions of R7 domain during force-increase scans at 1 pN s−1 and 5 pN s−1. The data points
obtained for analysis are N = 138 (1 pN s−1) and N = 103 (5 pN s−1), respectively. The curves are Gaussian fitting of the distribution with peaks at 10.1 ±
1.9 pN and 11.2 ± 1.1 pN, respectively. D, Left panel, typical force–bead height curves of the R7R8S1598D construct during force-increase scans at a loading
rate of 1 pN s−1. Right panel, the normalized unfolding force distributions of R7R8S1598D complex during force-increase scans at 1 pN s−1 and 5 pN s−1. The
data points obtained for analysis are N = 112 (1 pN s−1) and N = 136 (5 pN s−1), respectively. The curves are Gaussian fitting of the distribution with peaks at
9.7 ± 1.5 pN and 10.0 ±1.5 pN, respectively. The light gray and the dark gray dashed lines indicate the corresponding peak force values for R7R8 at 1 pN s−1
and 5 pN s−1, respectively.
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A direct interaction between talin and CDK1unfolded under the forces exerted at sites of adhesion. The
R7R8 region also provides linkages between IACs and the
cytoskeleton, and it connects to both the actin and microtu-
bule networks (Fig. 8). Specifically, the R7 domain binds the
KANK family of proteins (34, 50), which link to the cortical
microtubule stabilizing complex, and the R8 domain forms
part of the actin-binding site 2 (ABS2) that makes strong,
tension-bearing linkages to the actin cytoskeleton (23, 35). The
R7R8 domains are stabilized by a ladder of hydrogen bonds
between the linkers adjoining the two domains (38), which
makes the double domain one of the more stable regions in the
group III (15–21 pN) of talin rod domains (43). The S1589D
phosphomimetic R7R8 mutant is more susceptible to force
and unfolds at 10 pN. This raises the possibility that CDK1
binding to, and phosphorylation of, the R7R8 region might
regulate the association of talin with other IAC components
and the cytoskeleton. The accessibility of the VBS in R8 has
recently been shown to facilitate maturation of nascent ad-
hesions (51), suggesting that phosphorylation of S1589 during
the cell cycle might also regulate adhesion dynamics by con-
trolling the availability of this helix.
The talin-binding site on CDK1 also binds to the CKS
proteins that regulate CDK1 function (41). Therefore, talin and
CKS interactions with CDK1 should be mutually exclusive. It
is possible that the part of the CDK1 catalytic domain that
binds to talin and CKS is a CDK1-targetting domain, and its
interactions with various proteins relocate CDK1 to cellular
compartments where it can exert its effects. In addition,Figure 8. A cartoon to show how CDK1 regulation of talin mechanical
response might orchestrate global rearrangements of the cells cyto-
skeleton. Talin (white) acts as a Mechanosensitive Signaling Hub that co-
ordinates multiple cytoskeletal connections including microtubules (green),
mediated via KANK (pink) and the cortical microtubule stabilizing complex
(CMSC; gray) and actin (red), both directly and indirectly via vinculin
(orange). The cell signaling of each integrin adhesion complex will be
dependent on the conformational patterns of the talin binary switch do-
mains and the cytoskeletal connections. The R7R8 region of talin serves as a
nexus between the integrin adhesion complexes, microtubules, and actin
filaments. CDK1 (blue) binding to, phosphorylating, and altering the
mechanical response of the R7R8 domains has the potential to alter
these cytoskeletal linkages, which might trigger global cytoskeletal
rearrangement.mutating the CDK1 LD motif leads to a loss of CDK1 phos-
phorylation at T161, suggesting that this motif plays a key role
in upstream regulation of CDK1 function. Therefore, investi-
gating how binding partners of CDK1-WT and CDK1-2A
differ could elucidate key CDK1 regulatory mechanisms.
Binding of CDK1 to cyclin A requires prior phosphorylation of
T161, whereas binding of CDK1 to cyclin B occurs without
this phosphorylation (52), and we demonstrate that CDK1-2A
is still able to associate effectively with cyclin B, but is unable
to complex with cyclin A. Thus, the CDK1-2A mutant may
prove to be a useful tool for distinguishing the different roles of
CDK1-cyclin A and CDK1-cyclin B during cell cycle pro-
gression. In this context, expression of CDK1-2A leads to a
reduction in IACs and loss of IAC growth during S
phase, processes that we have previously attributed to
CDK1-cyclin A, implying its utility in elucidating the mecha-
nisms by which CDK1-cyclin A modifies IACs and the
cytoskeleton.
The observation that CDK1-dependent phosphorylation of
talin at S1589 alters the mechanical sensitivity of R7R8 has
implications for the role of talin as a mechanosensitive
signaling hub (27). This paradigm is based on the concept that
the talin scaffold that connects integrins to the cytoskeleton
can adopt many different conformations as a result of its bi-
nary switch patterns. These binary switches enable the cell to
alter its behavior in response to signaling, but also based on
prior events, imbuing the cell with mechanical memory (53).
The highly reproducible response of talin to mechanical force
is due to each of the talin switch domains having different
mechanical responses to force (43) and recruiting different
signaling molecules as a function of force. The phosphoryla-
tion of S1589 by CDK1 may therefore alter the order that the
talin switch domains unfold (Fig. 7). As further speculation,
the concept of mechanical computation of the cell (53), in
which the entire cytoskeletal architecture functions as a
computational assembly, predicts that cell architecture is
dictated by the signals that the cell has received and the cur-
rent patterns of mechanical switches in the cells. Alteration of
this pattern by talin S1589 phosphorylation might lead to
global changes to mechanotransduction downstream of talin.
Furthermore, other talin switch domains are also predicted to
be modified by PTM (Fig. S4) (54). It may be that talin
signaling, mechanotransduction via mechanical linkages, and
information storage in binary switches are controlled by PTMs
across many different tissues and scenarios. In this context,
cell polarity is a key driver of tissue self-organization and
coupling cell division to the geometry and mechanics of the
cytoskeletal machinery may provide a means of regulating the
polarity and organization of cells into tissues that underpins
multicellularity. Prior to division, most cells are attached to an
underlying ECM via IACs and/or to neighboring cells. While
modulation of adhesion occurs during interphase to enable
mitotic cell rounding and physical separation of daughter cells,
the links between the cell cycle and cell adhesion are poorly
understood. The novel interaction between talin and CDK1
identified in this report provides a framework for under-
standing these linkages.J. Biol. Chem. (2021) 297(1) 100837 11
A direct interaction between talin and CDK1Our studies demonstrate that CDK1 is able to phosphorylate
talin and switch talin into a state with different mechanical
properties, potentially altering the talin interactome and func-
tion in IACs. As talin is central to the downstream events
emanating from integrins, its interactionwith CDK1may enable
large-scale, synchronized changes to cell architecture to be
enabled during cell cycle progression and other adhesion-
related processes such as cell migration. Furthermore, it is
conceivable that changes in ECM stiffness sensed by talin may
impact upon CDK1 activity and function, providing a direct,
primordial link between mechanosensing and the induction of
cell proliferation. Defining the changes in the talin and CDK1
interactomes that result from CDK1-talin binding and the
knock-on consequences for adhesion and cell cycle signaling
will be a priority.
Experimental procedures
Antibodies and reagents
Monoclonal antibodies used were mouse anti-paxillin (clone
349; 1:500 for immunofluorescence; BD Biosciences; 610051),
mouse anti-cyclin B1 (Clone GNS3; 1:2000; MerckMillipore 05-
373), mouse anti-cyclin A2 (clone BF683; 1:1000, Cell Signaling
Technology 4656), mouse anti-CDK1 (clone POH1; 1:1000; Cell
Signaling Technology 9116), mouse anti-actin (clone AC-40;
1:2000; Sigma-Aldrich A3853), mouse anti-HA (clone 12CA5;
1:2000:ThermoFisherMA1-12429), and rabbit anti-CDK1pY15
(clone 10A11; 1:1000; Cell Signaling Technology 4539). Poly-
clonal antibodies used were rabbit anti-CDK1 (1:1000; Merck
Millipore; ABE1403), and rabbit anti-CDK1 pT161 (1:1000; Cell
Signaling Technology; 9114). Secondary Alexa-Fluor
680-conjugated (1:10,000; Thermo Fisher A10043) or DyLight
800-conjugated (1:10,000; Cell Signaling Technology 5257)
antibodies were used for immunoblotting. Anti-mouse and
anti-rabbit Alexa-Fluor 680-conjugated light-chain-specific
secondary antibodies were used (1:5000) for immunoblotting
immunoprecipitations (Jackson ImmunoResearch; 115-625-174
and 211-622-171). Anti-mouse and anti-rabbit Alexa-Fluor 488-
and 594-conjugated secondary antibodies (1:500) were used for
immunofluorescence (all from Thermo Fisher). Thymidine and
RO-3306 were purchased from Sigma-Aldrich. The cdc2-HA
plasmid was obtained from Addgene (#188818).
Protein purification
Expression constructs of talin were prepared using mouse
talin-1 DNA cloned into the expression vector pET151-TOPO,
expressed in E.coli BL21(DE3) Star and cultured in either
minimal media for NMR samples or LB for nonlabeled sam-
ples. Proteins were purified using nickel affinity chromatog-
raphy and the His-tag removed by TEV protease cleavage (55).
The protein was then further purified using ion exchange
chromatography. The protein constructs used were mouse
talin-1 R1-R3 (residues 482–911), R4-R8 (residues 913–1653),
R7R8 (residues 1357–1653), R8 (residues 1461–1580), R9-R10
(residues 1655–1973), R10 (residues 1815–1973), R11-R12
(residues 1974–2294), R13-DD (residues 2300–254), and
mouse talin-2 R7R8 (residues 1360–1656).12 J. Biol. Chem. (2021) 297(1) 100837Fluorescence polarization
The following peptides with a terminal cysteine residue were
synthesized by GLBiochem (Shanghai): CDK1(206–223)
GDSEIDQLFRIFRALGTP-C, CDK1-2A(206–223) GDSEAA
QLFRIFRALGTP-C, DLC1(465–489) IFPELDDILYHVKG
MQRIVNQWSEK-C, and KANK1(30–60) PYFVETPYGFQL
DLDFVKYVDDIQKGNTIKK-C (34). BODIPY-TMR coupled
peptides dissolved in PBS (137 mMNaCl, 27 mM KCl, 100 mM
Na2HPO4, 18 mM KH2PO4, pH 7.4), 5 mM TCEP, and 0.05%
(v/v) Triton X-100 were used at a final concentration of 0.5 μM.
Uncoupled dye was removed using a PD-10 gel filtration column
(GE Healthcare). Fluorescence polarization measurements were
recorded on a BMGLabTech CLARIOstar plate reader and
analyzed using GraphPad Prism (version 6.07). Kd values were
calculated by nonlinear curve fitting using a one site total and
nonspecific binding model.
NMR spectroscopy
NMR samples were prepared in 50 mM NaCl, 15 mM
NaH2PO4, 6 mM Na2HPO4, 2 mM DTT, pH 6.5, 5% (v/v)
D2O. All data were collected at a temperature of 298K on a
Bruker Avance III 600 MHz NMR spectrometer equipped with
CryoProbe. The spectra were processed using Topspin
(Bruker) and analyzed using CCPN Analysis (56). Backbone
resonance assignments of talin-1 R8 residues 1461 to 1580
were assigned previously (BMRB ID:19339 (32)).
X-ray crystallography
Talin-1 R7R8 was concentrated to 300 μM in 50 mM NaCl,
3 mM DTT, 20 mM Tris, pH 7.4, and incubated with CDK1
peptide in an 8:1 M excess. Sitting-drop sparse matrix crys-
tallization screening was performed using a Mosquito solution
handling robot (TTP Labtech) with 400 nl drops and a 1:1
precipitate:precipitant ratio. Crystals formed in 20% Iso-
propanol, 20% PEG4K, 0.1 M Na citrate, pH 5.6 at 4 C in 3 to
4 weeks. Crystals were vitrified in mother liquor containing
25% (v/v) glycerol in liquid nitrogen. Diffraction data were
collected on I24 (Diamond) and indexed and integrated using
the Xia2 3dii pipeline in space group P212121. The structure
was solved using molecular replacement using PHASER (57)
with the search model 2X0C and two copies of R7R8 present in
the asymmetric unit. Post molecular replacement electron
density for the CDK1 peptide was visible in the F0-FC differ-
ence map, allowing the unambiguous assignment of all side
chain positions. The structure was refined using Phenix 1.17
(58) and modeled using COOT (59). Data were refined using
isotropic B-factors and prior to deposition with a round of
weight optimization of both the stereochemical and B-factor
weights. Data reduction and refinement statistics are shown in
Table S3.
Cell culture, synchronization, and transfection
U2OS cells (European Collection of Cell Cultures 92022711;
Sigma-Aldrich) were maintained in DMEM (Sigma-Aldrich)
supplemented with 10% (v/v) FCS (Lonza), 1% (v/v) penicillin/
streptomycin, and 2 mM L-glutamine at 37 C, 5% (v/v)
A direct interaction between talin and CDK1CO2. For steady-state analysis of adhesion complexes in
asynchronous cells, cells were cultured on glass coverslips for
48 h and then treated with indicated compounds for 1 h. U2OS
cells were synchronized by using a double-thymidine block
protocol. Cells were plated, and after 24 h of growth, thymi-
dine was added to a final concentration of 2 mM, and the cells
were incubated for 16 h. Cells were then washed twice with
PBS and allowed to grow for 8 h in fresh DMEM. Thymidine
was then added to a final concentration of 2 mM for an
additional 16 h before cells were washed twice with PBS and
released into DMEM. U2OS cells were transfected with DNA
constructs by using Lipofectamine 3000 reagent (Sigma-
Aldrich) and siRNAs by using oligofectamine (Sigma-Aldrich)
according to the manufacturer’s instructions. Knockdown of
CDK1 was performed by using SMARTpool reagents (L-
003224-00-0005; GE Healthcare), and ON-TARGETplus
nontargeting siRNA (GE Healthcare) was used as a negative
control.
GFP-trap and mass spectrometry analysis
U2OS cells stably expressing talin-1-GFP or GFP were first
generated via transient transfection using Lipofectamine 2000
(Thermo Fisher Scientific) and selected using regular media
supplemented with 500 μg/ml of G418. Cells were then plated
on fibronectin for 2 h, washed with PBS, and lysed in CSK
buffer [0.5% (w/v) Triton X-100, 10 mM Pipes, pH 6.8,
150 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 10 mg/ml
leupeptin, 10 mg/ml aprotinin, 0.5 mM 4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride, 2 mM Na3VO4]. Ly-
sates were incubated with GFP-Trap agarose beads (Chro-
motek) for 1 h at 4 C. Complexes bound to the beads were
washed three times with ice-cold lysis buffer and eluted in
Laemmli reducing sample buffer. Protein samples were sepa-
rated by SDS-PAGE and following staining with InstantBlue
(Expedeon), gel lanes were sliced into ten 2-mm bands and
subjected to in-gel trypsin digestion (60). Samples were
analyzed by LC-MS/MS using an UltiMate 3000 Rapid Sepa-
ration LC (RSLC, Dionex Corporation) coupled to an Orbitrap
Elite (Thermo Fisher Scientific) mass spectrometer. Peptide
mixtures were separated using a gradient from 92% A (0.1% FA
in water) and 8% B (0.1% FA in acetonitrile) to 33% B, in
44 min at 300 nl.min−1, using a 75 mm × 250 μm i.d. 1.7
MBEH C18, analytical column (Waters). Peptides were auto-
matically selected for fragmentation by data-dependent anal-
ysis. Tandem mass spectra were extracted using extract_msn
(Thermo Fisher Scientific) executed in Mascot Daemon
(Matrix Science). Peak list files were searched against the
SwissProt human database (version 3.70, May 2013). Carba-
midomethylation of cysteine was set as a fixed modification,
and oxidation of methionine was allowed as a variable modi-
fication. Only tryptic peptides were considered, with up to one
missed cleavage permitted. Monoisotopic precursor mass
values were used, and only doubly and triply charged precursor
ions were considered. Mass tolerance for precursor and frag-
ment ions was 0.5 Da. Data were validated in Scaffold using the
following threshold: at least 80% probability at the peptidelevel, at least 99% probability at the protein level, and at least
two unique peptides. Relative protein abundance was calcu-
lated using the unweighted spectral count of a given protein
normalized to the total number of spectra observed in the
entire sample and to the molecular weight of that protein
(normalized spectral count). SAINT and FC_B scores were
calculated using the Resource for Evaluation of Protein
Interaction Networks (REPRINT) online tool (https://reprint-
apms.org/).
Proximity biotinylation, purification of biotinylated proteins,
and mass spectrometry analysis
U2OS cells were seeded onto plastic tissue culture plates
overnight, then transfected with BirA* empty vector or BirA*-
CDK1, and incubated for a further 16 h. Transfected cells were
then incubated in medium with 50 μM biotin for 24 h. Bio-
tinylated proteins were affinity purified following a protocol
adapted from Roux et al. (61, 62). Three 10-cm plates of cells
were washed three times in PBS, and cells were lysed with
400 μl lysis buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl,
0.1% [w/v] SDS, 0.5 mM DTT, and 1 × cOmplete Protease
Inhibitor Cocktail) at RT. 120 μl 20% (v/v) Triton X-100 was
added, and cell lysates were maintained at 4 C. DNA was
sheared by passing cell lysates through a 19G needle four times
before 360 μl chilled 50 mM Tris-HCl, pH 7.4, was added, and
then passing through a 27G needle four times. Cell lysates
were centrifuged at full speed for 10 min at 4 C, and super-
natant was rotated with 45 μl MagReSyn streptavidin beads
(ReSyn Biosciences) at 4 C overnight. Beads were washed
twice with 500 μl wash buffer 1 (10% [w/v] SDS), once with
500 μl wash buffer 2 (0.1% [w/v] deoxycholic acid, 1% [w/v]
Triton X-100, 1 mM EDTA, 500 mM NaCl, and 50 mM
HEPES), and once with 500 μl wash buffer 3 (0.5% [w/v]
deoxycholic acid, 0.5% [w/v] NP-40, 1 mM EDTA, and 10 mM
Tris/HCl, pH 7.4). Proteins were eluted in 40 μl of
2 × reducing sample buffer with 100 μM biotin for 10 min at
70 C. Eluted proteins were briefly subjected to SDS-PAGE
(3 min at 200 V, 4–12% Bis-Tris gel, Life Technologies) and
stained with InstantBlue Coomassie protein stain before being
washed with ddH2O overnight at 4 C. Bands were excised and
transferred to wells in a perforated 96-well plate, and in-gel
tryptic digestion was performed as previously described (60).
Peptides were desalted using 1 mg POROS Oligo R3 beads
(Thermo Fisher Scientific). Beads were washed with 50 μl 0.1%
(v/v) formic acid (FA) before the peptide solution was added.
Beads were washed twice with 100 μl 0.1% (v/v) FA, and
peptides were eluted twice with 50 μl 50% (v/v) acetonitrile
(ACN) and 0.1% (v/v) FA. Peptides were dried using a vacuum
centrifuge and resuspended in 11 μl 5% (v/v) ACN and 0.1%
(v/v) FA. Peptides were analyzed by liquid chromatography
(LC)-tandem MS (MS/MS) using an UltiMate 3000 Rapid
Separation LC (RSLC, Dionex Corporation) coupled to an
Orbitrap Elite mass spectrometer (Thermo Fisher). Peptides
were separated on a bridged ethyl hybrid C18 analytical
column (250 mm × 75 μm inner diameter, 1.7 μm particle
size, Waters) over a 1 h gradient from 8 to 33% (v/v) ACNJ. Biol. Chem. (2021) 297(1) 100837 13
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data-dependent mode to automatically select peptides for
fragmentation by collision-induced dissociation (CID). Quan-
tification was performed using Progenesis LC-MS software
(Progenesis QI, Nonlinear Dynamics; http://www.nonlinear.
com/progenesis/qi-for-proteomics/). In brief, automatic
alignment was used, and the resulting aggregate spectrum
filtered to include +1, +2, and +3 charge states only. A.mgf file
representing the aggregate spectrum was exported and
searched using Mascot Server Version 2.5.1 (tryptic peptides
only, monoisotopic m/z precursors, 2+ 3+ and 4+ charge
states, one missed cleavage, fixed modification: carbamido-
methyl [C]; variable modifications: biotinylation [B], oxidation
[M]; peptide tolerance: ±5 ppm; MS/MS tolerance: ±0.5 Da,
searched against the UniProtKB human database 2018_01
(January 31, 2018) consisting of 108,184,003 entries (Uni-
ProtKB/Swiss-Prot: 556,568 entries and UniProtKB/TrEMBL:
107,627,435 entries)), and the resulting.xml file was reim-
ported without filtering to assign peptides to features. The
estimated protein false discovery rate was 0.5% calculated us-
ing Scaffold (version 4.4.7; Proteome Software) using a
threshold of identification of at least 90% probability at the
peptide level, assignment of at least two unique peptides, and
at least 95% probability at the protein level. Three separate
experiments were performed, and abundance values for pro-
teins identified in the analysis using three or more peptides for
quantification by Progenesis were used to determine which
proteins were enriched over twofold in cells expressing BirA*-
CDK1 relative to cells expressing BirA*-empty vector control.Immunoprecipitation
U2OS cells transfected with GFP-tagged talin-1, GFP-tagged
ΔR8 talin-1, or GFP alone or synchronized in G2 9 h after
thymidine arrest (two 15-cm-diameter dishes per condition)
were lysed (500 μl per dish) in modified CSK buffer (150 mM
NaCl, 25 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1% (v/v) NP-
40), protease inhibitors (11836145001; Roche), and PhosStop
reagent (Roche). Lysates were passed five times through a
narrow-bore tip before centrifugation (10,000g for 3 min at
4 C). After centrifugation, 20 μl GFP-trap Sepharose beads
(Chromotek) or immunoprecipitating mAbs (mouse anti-
cyclin B1 clone GNS3 or mouse anti–cyclin A clone E67.1;
SC53230; Santa Cruz Biotechnology, Inc, or mouse IgG;
Sigma-Aldrich) were added to the lysate (2 μg/ml cyclin B1
and 10 μg/ml cyclin A final concentration) together with
protein G Sepharose (20 μl of 50% slurry bead volume; GE
Healthcare) for 16 h at 4 C. Sepharose beads were then
collected and washed two times in lysis buffer and once in
distilled H2O by centrifugation (2800g for 2 min). GFP-
associated or immunoprecipitated complexes were eluted
(30 μl) at pH 2 for 5 min at 25 C and neutralized according to
the manufacturer’s instructions (88805; Thermo Fisher Sci-
entific). Samples were then reduced at 70 C for 5 min by
dilution in 5× sample buffer (125 mM Tris, 10% (w/v) SDS,
25% (v/v) glycerol, 0.01% (w/v) bromophenol blue, and 10% (v/
v) β-mercaptoethanol) and subjected to SDS-PAGE and14 J. Biol. Chem. (2021) 297(1) 100837western blotting by using the Odyssey Infrared Imaging Sys-
tem. To avoid detection of antibody heavy chains, light-chain-
specific Alexa Fluor 680–conjugated secondary antibodies
were used (1:5000).
Immunofluorescence microscopy
U2OS cells were fixed in 4% (w/v) PFA for 20 min, washed
twice with PBS, and permeabilized by using 0.2% (w/v) Triton
X-100 in PBS for 10 min. Cells were then washed with PBS and
PFA quenched by incubation with 0.1 M glycine/PBS for
30 min. Cell were washed with PBS three times and then
incubated with primary antibodies (45 min at RT) and washed
with PBS containing 0.1% (w/v) Tween-20 (PBST) and incu-
bated for 30 min with the appropriate secondary antibodies
and, where applicable, Alexa Fluor dye–conjugated phalloidin
(Thermo Fisher Scientific). Finally, cells were washed three
times with PBST and once with distilled H2O before being
mounting on coverslips by using ProLong diamond antifade
reagent (Thermo Fisher Scientific) and imaging. Images were
acquired on an inverted confocal microscope (TCS SP5
Acousto-Optical Beam Splitter; Leica Microsystems) by using
a 63× objective (HCX Plan Apochromat, NA 1.25) and Leica
Confocal Software (Leica Microsystems), and image analysis
was performed using ImageJ. Images were background sub-
tracted by using rolling ball subtraction, and images of paxillin
staining (mouse anti-paxillin, clone 349, BD Biosciences) or
GFP-talin-1 were thresholded to define adhesion complexes.
By using a size cutoff of 0.2 μm, the total area of adhesion
complexes was determined per cell as a proportion of total cell
area. Representative cells were selected based on consistency
with phenotype observed across the field of view, with distinct
cells present within a similar density of surrounding cells being
chosen for analysis.
Total internal reflection fluorescence (TIRF) microscopy
U2OS cells stably expressing GFP-talin-1 constructs were
transfected with mScarlet-CDK1 using Lipofectamine 3000
according to manufacturer’s instructions. Cells were then
plated onto glass-bottomed dishes (Mat-tek), cultured over-
night, and fixed with 4% (w/v) PFA for 20 min, then washed
twice with PBS. Images were collected on a Leica Infinity TIRF
microscope using a 100×/1.47 HC PL Apo Corr TIRF Oil
objective with 488 nm and 561 nm diode TIRF lasers (with
30% laser power and a penetration depth of 110 nm) and an
ORCA Flash V4 CMOS camera (Hamamatsu) with 300 ms
exposure time and camera gain of 2. Images were background
subtracted by using rolling ball subtraction using ImageJ, and
representative images were selected based on consistency with
phenotype observed across the field of view.
Immunoblotting
Cells were lysed in lysis buffer (150 mM NaCl, 25 mM Tris-
HCl, pH 7.4, 1 mM EDTA, 1% (v/v) NP-40, 5% (v/v) glycerol,
1× protease inhibitor cocktail [Sigma Aldrich], and 1 × Phos-
STOP phosphatase inhibitor cocktail [Sigma-Aldrich]). Lysates
were clarified by centrifugation at 10,000g for 5 min at 4 C.
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gels; Thermo Fisher Scientific) under reducing conditions
and transferred to nitrocellulose membranes (Whatman).
Membranes were blocked for 60 min at RT using 5% (w/v)
BSA in TBS (10 mM Tris-HCl, pH 7.4, and 150 mM NaCl)
containing 0.05% (w/v) Tween-20 (TBST) and then probed
overnight with primary antibodies diluted in 5% (w/v) BSA/
TBST at 4 C. Membranes were washed for 30 min by using
TBST and then incubated with the appropriate fluorophore-
conjugated secondary antibody diluted in 5% (w/v) BSA/
TBST for 45 min at RT in the dark. Membranes were
washed for 30 min in the dark by using TBST and then
scanned by using the Odyssey infrared imaging system (LI-
COR Biosciences)
In vitro kinase assay
Purified recombinant GST-tagged CDK1-cyclin A2 and
His6-tagged CDK1-cyclin B1 (Invitrogen) were stored in
150 mM NaCl, 0.5 mM EDTA, 0.01% (v/v) Triton X-100,
2 mM DTT, 20% (v/v) glycerol 20 mM Tris, pH 7.5. 30 ng of
each protein were mixed with 0.1 μg of substrate (talin R7R8)
and incubated in 150 mM NaCl, 5 mM EDTA, 5 mM DTT,
25 mM MgCl2, 0.02% (v/v) Triton X-100, 1 mM ATP, 50 mM
HEPES, pH 7.4 at 30 C with shaking at 100 rpm for 20 min.
The reaction was stopped by adding SDS sample buffer and
boiled at 95 C for 10 min. A gradient SDS-PAGE 4 to 12%
Bis-Tris gel (Thermo Fisher Scientific) was loaded with the
entire sample and run at 200 V for 45 min in 1× SDS running
buffer (NuPAGE). After western blotting, antiphosphorylated
CDK substrate antibody (Cell Signaling Technology) was used
to probe the reactions.
Phosphorylation site analysis
Phosphorylation sites of talin-1 R7R8 were determined us-
ing mass spectrometry. The in vitro kinase assay was carried
out with the substrate talin-1 R7R8 and CDK1-cyclin A2.
Reactions was carried out for 45 min at 30 C and stopped by
adding SDS sample buffer and boiling for 10 min at 95 C. All
samples were loaded onto an SDS PAGE 4 to 12% Bis-Tris gel
(Thermo Fisher Scientific) and separated by running at 200 V
for 60 min. Gels were stained with Instant-Blue (Expedeon) for
15 min and washed in water overnight at 4 C. The talin R7R8
bands were cut from the gel and processed by in-gel tryptic
digestion. Peptides were analyzed by LC-MS/MS by using an
UltiMate 3000 Rapid Separation LC (Dionex Corporation)
coupled to an Orbitrap Elite MS (Thermo Fisher Scientific).
Peptides were separated on a bridged ethyl hybrid C18
analytical column (250 mm × 75 μm internal diameter, 1.7 μm
particle size; Waters) over a 45 min gradient from 8 to 33% (v/
v) acetonitrile in 0.1% (v/v) formic acid. LC-MS/MS analyses
were operated in data-dependent mode to automatically select
peptides for fragmentation by CID. Multistage activation was
enabled to fragment product ions resulting from neutral loss of
phosphoric acid. Quantification was performed using Pro-
genesis LC-MS/MS software.Single-molecule stretching
DNA fragments encoding the talin R7R8 domain (residues
1361–1654 of TLN1_MOUSE), talin R7 (residues 1361–1462
and 1578–1658 of TLN1_MOUSE), and talin R7R8S1589D
(residues 1361–1654 of TLN1_MOUSE with an S1589D mu-
tation) were synthesized by IDT block or PCR from template
DNA. Each target DNA fragment was then assembled with a
template vector (pET151: AviTag-(I27)2-Target-(I27)2-Spy-
Tag) containing an AviTag at the N-terminus, a SpyTag at the
C-terminus, and four repeats of titin I27 domains as a mo-
lecular handle using NEBuilder HiFi DNA assembly. The
sequence of all plasmids was verified by first base sequencing
service. Each plasmid was cotransformed with a BirA plasmid
and expressed in E. coli BL21(DE3) cultured in LB-media with
D-biotin and affinity purified using the 6His-Tag.
All single-molecule stretching experiments were performed
using magnetic tweezers (63–65) in standard buffered solution
comprising PBS, 1% (w/v) bovine serum albumin, 2 mM
dithiothreitol, 10 mM sodium L-ascorbate at 21 C ± 1 deg. C.
The height of the target molecule-tethered superparamagnetic
bead from the coverslip surface was recorded. At a constant
applied force, the bead height change was the same as the
molecule extension change (66). During linear force-increase/
force-decrease scans with typical loading rates of 0.1 to 10 pN
s−1, the stepwise bead height change was the same as the
stepwise extension change of the molecule. Over the time
window of the stepwise transition event (≤0.01 s, the temporal
resolution of this setup), the force change (≤0.001–0.1 pN) was
negligible. Force calibration of the magnetic tweezer has 10%
uncertainty due to the heterogeneity of the paramagnetic
beads (63). Each single-molecule protein construct contained a
biotinylated AviTag at its N-terminus, a target domain span-
ned between four repeats of titin I27 domains, and a SpyTag at
its C-terminus (67). Between each two neighboring molecular
components in the construct, a short linker, GGGSG, was
included to ensure flexibility of the components. The C-ter-
minus of the protein construct was specifically attached to a
SpyCatcher-coated coverslip surface (Paul Marienfield), and
the N-terminus of the construct was attached to a biotinylated
DNA-coated paramagnetic bead (2.8 μm diameter, Invitrogen)
via a biotin–neutravidin interaction. The four repeats of I27
domains and the DNA handle acted as a molecular spacer to
avoid nonspecific bead–surface interactions. The I27 domain
has an ultrahigh mechanical stability in that it typically unfolds
at >100 pN with a characteristic step size of 24 nm at force
loading rates 1 to 5 pN s−1 (68). Hence it can be distinguished
from the target domain unfolding signals and does not affect
the probing and characterization of the target domains.
Data availability
The atomic coordinates were deposited with the Protein
Data Bank, accession code 6TWN.
The talin-1-GFP-Trap mass spectrometry proteomics data
are given in Table S1 and have been deposited to the Pro-
teomeXchange Consortium via the PRIDE (69) partnerJ. Biol. Chem. (2021) 297(1) 100837 15
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10.6019/PXD024634.
The BirA*-CDK1 proximity biotinylation mass spectrom-
etry proteomics data are given in Table S2 and have been
deposited to the ProteomeXchange Consortium via the PRIDE
(69) partner repository with the data set identifier PXD024796
and 10.6019/PXD024796.
All other data are contained within the article and the
accompanying supporting information.
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